מתוך medicontext.co.il
WESTPORT, CT (Reuters Health) – Treatment with dehydroepiandrosterone (DHEA) is similar to that with estrogen-progestin replacement therapy in its effects on several endocrine parameters in postmenopausal women, Italian physicians report.
Dr. Alessandro D. Genazzani, now with the University of Modena, and associates from the University of Pisa treated 31 women with oral DHEA 50 mg daily for 6 months. The subjects were grouped according to age and body mass index. Hormone evaluations and a growth hormone releasing hormone (GHRH) test were performed before and after the trial.
"Oral DHEA treatment annulled the differences observed between early and late postmenopause, including those strictly related to excess body weight," the physicians write in the August issue of Fertility and Sterility.
Plasma levels of steroids that derived from DHEA metabolism increased, as did osteocalcin, growth hormone (GH), and insulin-like growth factor 1 (IGF-1). Levels of luteinizing hormone and follicle stimulating hormone decreased.
DHEA treatment was similar in its effect on the GHRH-GH-IGF-1 axis as treatment with estrogen-progestin, Dr. Genazzani's group concludes. They recommend that DHEA be considered not just a diet supplement but an effective hormone replacement treatment.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!